As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/26/24  Actinium Pharmaceuticals, Inc.    10-Q        3/31/24   49:10M                                    EdgarAgents LLC/FA       
 3/29/24  Actinium Pharmaceuticals, Inc.    S-8         3/29/24    4:57K                                    EdgarAgents LLC/FA       
 3/29/24  Actinium Pharmaceuticals, Inc.    10-K       12/31/23   65:17M                                    EdgarAgents LLC/FA       
  2/9/24  Bigger Capital, LLC               SC 13G/A               1:230K Actinium Pharmaceuticals, Inc.    Olshan Frome Wolosky LLP 
  2/5/24‡ Actinium Pharmaceuticals, Inc.    EFFECT       2/5/24    1:2K                                     SEC #5                   
  2/2/24  Actinium Pharmaceuticals, Inc.    S-3/A                  3:589K                                   EdgarAgents LLC/FA       
  2/2/24  Actinium Pharmaceuticals, Inc.    CORRESP¶     3/5/24    1:6K                                     EdgarAgents LLC/FA       
 1/29/24  BlackRock Inc.                    SC 13G                 1:13K  Actinium Pharmaceuticals, Inc.    Blackrock Advisors LLC   
12/29/23  Nicholson, C. David               4          Director²   1:5K   Actinium Pharmaceuticals, Inc.    EdgarAgents LLC/FA       
12/29/23  Steinhart Richard I               4          Director²   1:5K   Actinium Pharmaceuticals, Inc.    EdgarAgents LLC/FA       
12/29/23  O’Loughlin Steve                  4          Officer²    1:5K   Actinium Pharmaceuticals, Inc.    EdgarAgents LLC/FA       
12/29/23  Shetty Ajit                       4          Director²   1:5K   Actinium Pharmaceuticals, Inc.    EdgarAgents LLC/FA       
12/29/23  Seth Sandesh                      4          Dir.,Off.²  1:5K   Actinium Pharmaceuticals, Inc.    EdgarAgents LLC/FA       
12/29/23  Chell Jeffrey W.                  4          Director²   1:5K   Actinium Pharmaceuticals, Inc.    EdgarAgents LLC/FA       
 12/1/23  Actinium Pharmaceuticals, Inc.    8-K:5      11/30/23   10:189K                                   EdgarAgents LLC/FA       
 11/9/23  Actinium Pharmaceuticals, Inc.    ARS        12/31/22    1:810K                                   EdgarAgents LLC/FA       
 11/9/23  Actinium Pharmaceuticals, Inc.    DEF 14A    11/30/23    1:5.1M                                   EdgarAgents LLC/FA       
 11/2/23  Actinium Pharmaceuticals, Inc.    10-Q        9/30/23   46:4.2M                                   EdgarAgents LLC/FA       
 8/17/23  SEC                               UPLOAD¶      3/5/24    2:39K  Actinium Pharmaceuticals, Inc.                             
 8/14/23  Actinium Pharmaceuticals, Inc.    10-Q        6/30/23   45:4M                                     EdgarAgents LLC/FA       

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  /A
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	ARS	Annual Report to Security Holders.
	CORRESP	Comment-Response or Other Letter to the SEC.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	EFFECT	SEC Notice of Effectiveness.
	S-3	Registration Statement – Securities for a Transaction — Form S-3.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	UPLOAD	Comment or Other Letter from the SEC.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
	¶	This Filing contains a delayed-release Document.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.